Print Page     Close Window     

Investors Overview

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has nearly 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.

Acquisition of C.R. Bard - Frequently Asked Questions for Shareholders

Acquisition of C.R. Bard – Historical Comparable Revenue Schedules

Acquisition of CareFusion - Frequently Asked Questions for Shareholders


Q1 2018 Earnings Presentation
Download Documentation (Download PDF)

Annual Meeting of Shareholders Presentation
Download Documentation (Download PDF)

36th Annual J. P. Morgan Healthcare Conference Presentation
Download Documentation (Download PDF)


Thursday, May 3, 2018 8:00 a.m. ET
Q2 2018 BD Earnings Conference Call